Tokyo, Nov. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059685) titled 'Multicenter Prospective Study on the Usefulness of Indigo Carmine Chromoendoscopy for Detecting Gastric Cancer and Adenoma During Upper Gastrointestinal Endoscopy' on Nov. 7.
Study Type:
Observational
Primary Sponsor:
Institute - Kanagawa Cancer Center
Condition:
Condition - early gastric cancer and gastric adenoma
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to prospectively evaluate the usefulness of spraying indigo carmine throughout the entire stomach during surveillance endoscopy for detecting gastric cancer or adenomas.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - 1) Patients who meet at least one of the following criteria.
1. History of endoscopic treatment for gastric cancer or gastric adenoma
2. Currently diagnosed with early-stage gastric cancer, advanced gastric cancer, or gastric adenoma (known lesions are excluded)
2) Age: 20 years or older, 95 years or younger
3) Written informed consent has been obtained.
Key exclusion criteria - 1) Patients after gastric or esophageal surgical resection
2) Patients who cannot undergo a biopsy
3) Pregnant patients
Target Size - 1050
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 08 Month 20 Day
Date of IRB - 2025 Year 11 Month 04 Day
Anticipated trial start date - 2025 Year 11 Month 04 Day
Last follow-up date - 2030 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066171
Disclaimer: Curated by HT Syndication.
